1-3 of 3
Denise Wolleschak, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inflammation Induced Expression of Ybx1 Mediates Resistance to JAK-Kinase Inhibitor Therapy in Myeloproliferative Neoplasia

Carolin Herzog, Anja Polanetzki, Stephanie Frey, Tina M Schnoeder, PhD, Denise Wolleschak, MD, Nomusa Mashamba, MSc, Veera Raghavan Thangapandi, Kathleen Jentsch-Ullrich, MD, Christoph Kahl, MD, Nicolas Schroeder, MD, Peter R Mertens, MD, Thomas Fischer, MD, Florian H Heidel, MD
Journal: Blood
Blood (2014) 124 (21): 161.
https://doi.org/10.1182/blood.V124.21.161.161
Published: 2014
Journal Articles

Specificity of JAK-Kinase Inhibition Determines Impact on T-Cell Function

Florian Perner, Felix C Saalfeld, cand.MD, Tina M Schnoeder, PhD, Denise Wolleschak, MD, Corinna Fahldieck, Satish Ranjan, Berend H Isermann, MD, Katrin Hebel, PhD, Monika Brunner-Weinzierl, PhD, Thomas Fischer, MD, Florian H Heidel, MD
Journal: Blood
Blood (2014) 124 (21): 1410.
https://doi.org/10.1182/blood.V124.21.1410.1410
Published: 2014
Journal Articles

FLT3-Kinase Inhibitors Quizartinib and Midostaurin Do Not Impair T-Cell Reactivity and Activation

Denise Wolleschak, MD, Thomas S. Mack, MSc, Florian Perner, Tina M Schnoeder, PhD, Marie-Christine Wagner, Stefanie Kliche, PhD, Burkhart Schraven, Satish Ranjan, Berend H. Isermann, MD, Daniel B. Lipka, MD, Thomas Fischer, MD, Florian H Heidel, MD
Journal: Blood
Blood (2012) 120 (21): 1045.
https://doi.org/10.1182/blood.V120.21.1045.1045
Published: 2012